Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constance Thibault

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Drug Design, Development and Therapy|September 19, 2017
Radium 223 dichloride for prostate cancer treatmentEmmanuel Deshayes, Mathieu Roumiguie, Constance Thibault, et al.
Plos Medicine|December 28, 2016
Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective StudyNicolas Pécuchet, Eleonora Zonta, Audrey Didelot, et al.
Bulletin Du Cancer|January 23, 2026
[Optimizing management of metastatic castration-sensitive prostate cancer: From therapeutic advances to personalized care]Yann Neuzillet, Constance Thibault, Loïc Mourey, et al.
Lung Cancer (Amsterdam, Netherlands)|November 29, 2024
Validation of the Lung Immune Prognostic Index in patients with untreated advanced non-small cell lung cancer: Post hoc analysis of the IMpower 130, 131 and 150 trialsEdouard Auclin, Matthieu Roulleaux Dugage, Teresa Gorria, et al.
BJU International|April 4, 2017
Safety and efficacy of 2-weekly cabazitaxel in metastatic castration-resistant prostate cancerAlice Clément-Zhao, Marie Auvray, Hail Aboudagga, et al.
Cancer Medicine|August 12, 2021
Cabazitaxel multiple rechallenges in metastatic castration-resistant prostate cancerCedric Pobel, Edouard Auclin, Diego Teyssonneau, et al.
European Journal of Human Genetics : EJHG|May 6, 2025
Predisposition to prostate cancer and clinical implications in a real-life cohortJulie Chartier, Albain Chansavang, Anne Jouinot, et al.
European Urology Oncology|March 20, 2026
Blood and Urine Circulating Tumor DNA in Urothelial Bladder Cancer: State of the Art and Clinical PerspectiveIgor Duquesne, Isabelle Epelbaum, Doriane Prost, et al.
Cancer Treatment Reviews|May 20, 2021
Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical dataPhilippe Barthélémy, Nathalie Rioux-Leclercq, Constance Thibault, et al.
European Urology Oncology|April 22, 2026
Integrated Prognostic Score in Metastatic Castration-resistant Prostate Cancer Treated with Cabazitaxel - A CABASTY Post Hoc Analysis Validated by Two International Prospective Phase 3 TrialsCharles Vauchier, Constance Thibault, Maud Velev, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Drug Design, Development and Therapy|September 19, 2017
Radium 223 dichloride for prostate cancer treatmentEmmanuel Deshayes, Mathieu Roumiguie, Constance Thibault, et al.
Plos Medicine|December 28, 2016
Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective StudyNicolas Pécuchet, Eleonora Zonta, Audrey Didelot, et al.
Bulletin Du Cancer|January 23, 2026
[Optimizing management of metastatic castration-sensitive prostate cancer: From therapeutic advances to personalized care]Yann Neuzillet, Constance Thibault, Loïc Mourey, et al.
Lung Cancer (Amsterdam, Netherlands)|November 29, 2024
Validation of the Lung Immune Prognostic Index in patients with untreated advanced non-small cell lung cancer: Post hoc analysis of the IMpower 130, 131 and 150 trialsEdouard Auclin, Matthieu Roulleaux Dugage, Teresa Gorria, et al.
BJU International|April 4, 2017
Safety and efficacy of 2-weekly cabazitaxel in metastatic castration-resistant prostate cancerAlice Clément-Zhao, Marie Auvray, Hail Aboudagga, et al.
Cancer Medicine|August 12, 2021
Cabazitaxel multiple rechallenges in metastatic castration-resistant prostate cancerCedric Pobel, Edouard Auclin, Diego Teyssonneau, et al.
European Journal of Human Genetics : EJHG|May 6, 2025
Predisposition to prostate cancer and clinical implications in a real-life cohortJulie Chartier, Albain Chansavang, Anne Jouinot, et al.
European Urology Oncology|March 20, 2026
Blood and Urine Circulating Tumor DNA in Urothelial Bladder Cancer: State of the Art and Clinical PerspectiveIgor Duquesne, Isabelle Epelbaum, Doriane Prost, et al.
Cancer Treatment Reviews|May 20, 2021
Non-clear cell renal carcinomas: Review of new molecular insights and recent clinical dataPhilippe Barthélémy, Nathalie Rioux-Leclercq, Constance Thibault, et al.
European Urology Oncology|April 22, 2026
Integrated Prognostic Score in Metastatic Castration-resistant Prostate Cancer Treated with Cabazitaxel - A CABASTY Post Hoc Analysis Validated by Two International Prospective Phase 3 TrialsCharles Vauchier, Constance Thibault, Maud Velev, et al.
Pageof 11